How is neuromuscular weakness evaluated during CP-ICU mobilization planning?

• A. Medical Research Council sum score, handgrip strength, and functional measures
• B. Handgrip strength only
• C. Electromyography testing
• D. Imaging findings of muscle mass

Answer: (A)

Assessing neuromuscular weakness in CP-ICU mobilization planning relies on a combination of bedside strength testing and functional measures. The Medical Research Council sum score uses manual muscle testing of multiple muscle groups on both sides to quantify overall strength, producing a total score that helps define the presence and severity of ICU-acquired weakness. It’s practical at the bedside and provides a standardized benchmark for deciding how aggressively to mobilize.

Handgrip strength adds a quick, reliable indicator of overall muscle function that often correlates with broad strength and functional outcomes. It’s easy to perform and can be used when full comprehensive testing is not feasible due to patient fatigue or cognitive issues, yet it still informs planning.

Functional measures capture how weakness translates into actual activities the patient needs for mobilization, such as transfers, sit-to-stand ability, and ambulation capabilities. These measures ensure that the plan targets real-world tasks and helps predict safe progression of activity.

Other options, like electromyography, are more invasive and specialized and don’t directly guide bedside mobilization decisions. Imaging to assess muscle mass shows quantity but not functional capacity, so it’s less useful for planning mobilization strategies in the acute setting.

Using the combination of MRC sum score, handgrip strength, and functional measures gives a comprehensive, actionable picture of neuromuscular weakness to guide CP-ICU mobilization.